RxDoctor Payments Data

Kalpesh Mehta, DO

Gastroenterology · Bellflower, CANPI 1952460610

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $985, 3.1 times the $320 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in CA, where the typical reported total is $1,790.

$2,068in general payments, 2019–2025

Across 20 payments — averaging $103.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$445
  • AbbVie$320
  • Medtronic$143
  • Madrigal Pharmaceuticals$138
  • Johnson & Johnson$131
  • Aimmune Therapeutics, Inc.$125
  • plus $766 from 7 others

What the payments were for

  • Food & beverage$2,061100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,068 in reported general payments places this provider in the 50th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$2,760
Medicare patients
12
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl334$7,508
Pantoprazole Sodium195$2,512
Omeprazole23$232
Famotidine18$158

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Bellflower

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →